Line 35: |
Line 35: |
| ===Clinical Signs=== | | ===Clinical Signs=== |
| | | |
− | First clinical signs are characterized by lethargy,
| |
− | dehydration, anorexia, and weight loss followed by a more
| |
− | pronounced clinical manifestation depending on the predominantly
| |
− | affected organ. Development of a biphasic fever
| |
− | represents another characteristic clinical finding (Wright
| |
− | et al., 1974). A transient fever and the onset of lymphopenia
| |
− | can be observed 3–6 days pi (Krakowka et al., 1980) and
| |
− | coincide with the first viremia that results in a generalized
| |
− | infection of all lymphoid tissues including spleen, thymus,
| |
− | lymph nodes, bone marrow, mucosa-associated lymphatic
| |
− | tissues(MALT) and macrophages in the lamina propria of the
| |
− | gastrointestinal tract (Appel, 1970; Wright et al., 1974), as
| |
− | well as hepatic Kupffer cells (Appel, 1987). Viremia occurs
| |
− | by spread of cell free virus as well as leukocyte and
| |
− | thrombocyte associated infectious pathogens. The second
| |
− | viremia follows several days later, frequently associated
| |
− | with high fever, and results in infection of parenchymal and
| |
− | tissue cells throughout the body (Appel, 1969; Appel and
| |
− | Gillespie, 1972; Blixenkrone-Møller, 1989; Blixenkrone-
| |
− | Møller et al., 1989; Okita et al., 1997). Thus, CDV can be
| |
− | found in cells of the respiratory, gastrointestinal and urinary
| |
− | tract, endocrine system, lymphoid tissues, central nervous
| |
− | systemand vasculature including keratinocytes, fibroblasts,
| |
− | thrombocytes and different lymphoid cell subsets, aswell as
| |
− | bronchial, endothelial, epithelial and neuroectodermal cells
| |
− | (Baumga¨ rtner et al., 1989; Gro¨ne et al., 2004a,b; Koutinas
| |
− | et al., 2004).
| |
| 5.2. Clinical manifestations | | 5.2. Clinical manifestations |
| According to clinical features a catarrhal and nervous | | According to clinical features a catarrhal and nervous |